Skip to main content
Fig. 4 | BMC Anesthesiology

Fig. 4

From: Supreme™ laryngeal mask airway insertion requires a lower concentration of sevoflurane than ProSeal™ laryngeal mask airway insertion during target-controlled remifentanil infusion: a prospective randomised controlled study

Fig. 4

Dose-response curves plotted from logistic analysis of individual end-tidal sevoflurane concentrations and the respective reactions to PLMA or SLMA insertion. ET50 in PLMA group: 1.15%; ET50 in SLMA group: 0.43%; ET95 in PLMA group: 2.43%; ET95 in SLMA group: 1.50%

Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us